Grants Dashboard

The Oklahoma Strategic Prevention Framework for Prescription Drugs (SPF Rx2) program will address prescription drug misuse, particularly prescription opioids among Oklahomans of all ages. The purpose of the Oklahoma SPF Rx program is to improve community understanding of the dangers of prescription drug misuse through community-based prevention actions and partnerships with the Healthcare sector. The project will raise awareness about the risks of sharing medications, and promote collaboration between the state, tribes, pharmaceutical and medical communities to increase the use of the Oklahoma Prevention Monitoring Program (PMP) and improve prescribing practices. Oklahoma will leverage the success of the Strategic Prevention Framework State Partnership For Success (SPF-PFS) grant and current SPF Rx grant to further develop the necessary infrastructure and capacity to accomplish the following goals over a five-year period: (1) Utilize the SPF in two high need communities to reduce priority prescription opioid problems; and (2) Improve utilization of healthcare sector opioid prescribing quality improvement programs in two high need communities. This will be accomplished through (1) strategic planning at the state and local levels, (2) collaborating with state agencies, tribes, and the pharmaceutical and medical communities to increase the use of the Oklahoma Prevention Monitoring Program (PMP) and improve prescribing practices; (3) engaging key community stakeholders; (4) continually monitoring data from the Oklahoma PMP; (5) enrolling prescribers in practice dissemination programs aimed at increasing the utilization of evidence-based pain and opioid management guidelines; and (6) using the OKImReady communication campaign at the state and local levels to continue to educate Oklahomans on substance use prevention, treatment, and recovery with a special focus on opioid use disorder, serving an estimated 1,250,000 Oklahomans per year and 1,500,000 over the lifetime of the project. The Oklahoma Department of Mental Health and Substance Abuse Services, as the Single State Agency, is well-positioned and equipped to effectively coordinate the SPF Rx2, and has demonstrated success in preventing and reducing substance use problems.

Ohio's Strategic Prevention Framework for Prescription Drugs Grant 2021 will raise awareness bout the dangers of prescription drug misuse, work with the pharmaceutical and medical communities on the risks of over prescribing and increase the utilization of the Ohio's Automated Rx Reporting System (OARRS). It will enhance infrastructure and prescription drug prevention throughout Ohio focused on targeted metropolitan communities. The number of expected people served during the project will depend on the targeted communities and strategies selected with guidance from SAMSHA's Opioid Overdose Prevention Toolkit.

The goal of Maine’s Comprehensive Approach to Address Prescription Drug Misuse Project (CAA-PDM) is to increase the number of citizens living safe, healthy, and productive lives by decreasing opioid and stimulant misuse, dependence, and drug overdose deaths in Maine. This will be accomplished through raising awareness about the risks of misusing or sharing medications, educating medical providers and prescribers on recommended alternatives to opioid or stimulant prescriptions as well as safe policies for prescription monitoring and tapering, and increasing community prevention activities in areas with the greatest need. The Maine CAA-PDM project will enhance prevention strategies and reach populations and stakeholders who have yet to be actively involved in evidence-based practices for controlled prescription safety. The project will focus on all Maine citizens ages 12 and older, medical and pharmaceutical providers, and endeavor to reach communities not previously reached by this grant, such as veterinary hospitals, dentists, and VA Healthcare facilities and the other priority populations such as the refugee/immigrant communities. In the first year’s strategic planning process, enhancements to both the Maine PMP and SEOW dashboard will be used to identify areas of greatest need at both the state and community levels which will direct resources where they are needed most and facilitate the implementation of targeted strategies. In addition, through collaboration with various existing stakeholder groups, a training curriculum for medical providers will be developed and implemented on topics including safe opioid prescribing practices education, safe medication tapering, and when to choose alternative treatment. Community level targeted prevention strategies will be selected and recommended for the recipients of the grants we will offer to locate new local collaborations. Those strategies will be recommended for communities to carry out using the SPF process as well as community level data from the Prescription Monitoring Program and the State Epidemiological Outcomes Workgroup. Mass reach health communications will be developed and used in conjunction with localized social media campaigns to raise awareness in Maine about the dangers of prescription drug misuse along with other opioid and stimulant prevention related messages. The project goals are to; 1) Increase knowledge, attitudes, and beliefs about the dangers of prescription drug misuse; 2) Decrease prescription drug overdose deaths; 3) Enhance Maine’s data infrastructure and surveillance data gathering tools to better inform. Success of this project will be measured by a decrease in overdose deaths, an increase of evidence based policies and practices implemented at the local level and an enhanced data infrastructure system to proactively address the areas of highest need with evidence based resources, interventions and support.

The IL SPF Rx project will address 3 main goals focusing on prescription drug misuse: use PMP data and the SPF to design prevention activities; expand the infrastructure of healthcare professionals who understand the SPF, PMP, and dangers of prescription drug misuse by training healthcare students and integrating information in curricula; and deliver activities based on current facts and evidenced-based strategies to prevent misuse by high school students. The Illinois Department of Human Services Division of Substance Use Prevention and Recovery (IDHS/SUPR) submits this application for SAMHSA/CSAP Funding Opportunity Announcement (FOA) SP-21-001, Strategic Prevention Framework for Prescription Drugs (SPF Rx) grant. The IDHS/SUPR Bureau of Prevention Services manages prevention funds of Illinois Substance Abuse Block Grant, as well as many previous SPF grants. Illinois proposes to train medical communities on risks of overprescribing to young adults, increase awareness and access of the PMP by healthcare professionals, and raise community awareness by bringing prescription drug misuse prevention activities and education to high schools. IL PMP data will inform needs assessments and strategic plans as indicators of project outcomes to reduce the number of prescription drug misuse, overdose-related deaths, and prescription misuse adverse events among individuals 18 years and older. To achieve these outcomes, more than 600 healthcare students will be trained and 600 high schoolers are estimated to receive prevention activities in Year 1. Over 5 years, more than 6,000 individuals will be trained/impacted by prevention activities. One sub-recipient will serve areas in Illinois identified by the SPF driven needs assessment using PMP data. Current data identifies Cook county as the hub of overrepresented overdose deaths mainly due to fentanyl, yet a need for prevention services targeting high school youth has received less attention even though the number of emerging adults who misuse prescription drugs increases compared to low rates for adolescents. Illinois Youth Survey data points to potential risk factors including multiple drug use associated with adolescent prescription drug misuse. The sub-recipient will coordinate and provide training of healthcare students to provide prescription drug misuse prevention/education activities to high school youth. Most trainers will be college age to potentially increase acceptance of trainers and their messages. The Evaluator and sub-recipient will assist IDHS/SUPR in complying with SAMHSA/CSAP reporting expectations. The sub-recipient will assist IDHS/SUPR in local needs assessments and expansion of sectors represented on the Illinois Opioid Crisis Response Advisory Council through the Prescribing Practices Committee and Equity Committee. The committees will build on strategic planning and SPF activities, as well as contribute to state and local policy/legislative changes.

The Alabama Strategic Prevention Framework Prescription: Only Yours As Prescribed 2.0 (ASPFRx OYAP 2.0) project seeks to prevent and reduce prescription drug misuse and the negative consequences associated with it while improving capacity and infrastructure in communities with health disparities, less access to care, and poorer behavioral health outcomes in young adults in the identified high need populations within the state. The targeted regions will have high concentrations of individuals with significant health disparities, elevated levels of substance use, poverty, and less access to care resulting in poorer behavioral health outcomes. The population of focus will be young adults aged 18-25 with a specific focus on deaf and/or hard of hearing individuals. The project seeks to continue utilization of a structured approach set forth by the existing strategic planning framework, the strategic prevention framework for prescription drugs, and implementation of evidence-based practices and programs with sound evaluation to reach identified populations. The goals of the project are to: (1) Prevent and reduce young adult prescription drug misuse in communities with health disparities; (2) Reduce prescription misuse-related problems in Alabama communities that have less access to care and poorer behavioral health outcomes; and (3) Improve prevention capacity, coordination and infrastructure at the state and community levels. The objectives the project seeks to attain are: (1) By 2026, prevent and reduce prescription drug misuse and its negative consequences among young adults aged 18-25 by 3%; (2) Annually identify and collaborate efforts with pharmaceutical and medical communities, per region (four regions), to address the risks of overprescribing; and (3) Provide outreach and awareness initiatives, tools, trainings, and technical assistance to a minimum of 400 individuals per year, 100 individuals per region, on approaches to ensure successful outcomes are sustained over time resulting in a minimum of 2,000 individuals reached during the project period. A comprehensive approach utilizing the six CSAP strategies will comprise the strategies/interventions to address the goals and objectives. Information Dissemination, Education, Alternatives, Community Based Processes, Environmental and Problem Identification and Referral strategies will address risk and protective factors and include culturally appropriate information about prescription drug misuse as it relates to individual communities. The inclusion of the educational system collaborative efforts and supportive services, youth/parent after-school involvement with prescription drug misuse initiatives and youth mentorship/recruitment efforts, representation of the recovery community, constituent initiatives to address policies such as prescription drug availability, Alabama Department of Mental Health's Office of Deaf Services, Alabama's Prescription Drug Monitoring Program (PDMP), prescribers and patient awareness will be integral to the success of the ASPFRx OYAP 2.0 project.

The Massachusetts SPF Rx Project has as its goal to develop a strategic plan that will address prescription drug misuse, engage partners, conduct activities that raise awareness about the dangers of sharing medications—including opioids, benzodiazepines and stimulants—and work with pharmaceutical and medical communities on the risks of overprescribing to young adults. Massachusetts has identified its overall population of focus for the prevention of substance use disorder (SUD) as being those at highest risk of opioid overdose or other SUD, including the potential of prescription drug misuse. Key objectives are: (1) Strategic planning: By the end of year 2, develop a strategic plan that identifies communities with high rates of potentially inappropriate prescribing or prescription drug use and prioritizes activities for primary and secondary prevention efforts; update the plan annually in years 3-5. (2) Engagement and work groups: By month 3 establish an advisory and engagement structure; and by the end of year 2 engage individuals and organizations from 100% of the following sectors in the strategic planning process: community members, healthcare providers, key stakeholders, adult, youth, young adults, elders, and youth and families and people in recovery from substance use disorder. (3) PDMP: By end of year 4, provide community stakeholders with easy-to-use tools for tracking and displaying trends of prescription medications with high misuse potential by incorporating selected MA PMP prescription drug use data sets and interactive charts and maps into the state’s public data portal—the Massachusetts Population Health Information Tool. (4) Other implementation activities: By no later than Year 4, develop and implement activities statewide or in targeted communities to: (a) conduct a community-based public education campaign to increase awareness of prescription drug misuse; (b) continue to educate prescribers on the use and benefits of accessing the MA PMP; (c) continue to collaborate with pharmacies to ensure timely input into the MA PMP database; and (d) conduct medication disposal programs, and effective law enforcement activities aimed at reducing inappropriate prescribing and multiple provider episodes (i.e., doctor shopping).

The Pennsylvania Strategic Prevention Framework for Prescription Drugs (SPF Rx) Project proposes to increase knowledge among adolescents and young adults of the risks of controlled substances, ultimately reducing misuse and associated opioid overdose deaths within identified high need counties. These goals will be achieved by deploying targeted multi-media campaigns to the public, prescribers, and dispensers. Adolescents and young adults aged 15-24 will be a specific population of focus for this project. The Pennsylvania Department of Health (DOH) has identified the following project objectives: 1) Increase awareness and knowledge of the dangers of prescription drug misuse; 2) Increase prescriber and dispenser utilization of the Prescription Drug Monitoring Program (PDMP); 3) Increase utilization of PDMP data in local overdose prevention program planning, implementation, and evaluation. These goals will be achieved by deploying targeted multi-media campaigns to raise awareness of dangers of prescription drug misuse amongst adolescents and young adults (age 15-24); creating strategic messaging and outreach to prescribers and dispensers regarding utilization of the PDMP and application of the Pennsylvania Prescribing Guidelines; and engaging state and local stakeholders relevant to the goals of the project. The Pennsylvania Department of Health, Office of Drug Surveillance and Misuse Prevention (ODSMP), as the lead agency, will utilize the Strategic Prevention Framework model to plan, implement, and evaluate media campaigns and outreach activities. The ODSMP will engage Pennsylvania’s Opioid Command Center to maximize cohesion with existing work underway in the Commonwealth. The Opioid Command Center consists of 16 state agencies, the Office of Attorney General, and the High Intensity Drug Trafficking Area (HIDTA) and is responsible for leading the Commonwealth’s response to the opioid crisis. Additionally, the ODSMP will establish a workgroup consisting of local stakeholders from the identified high need counties to provide guidance on the project.

The North Carolina Strategic Prevention Framework for Prescription Drugs (SPF-Rx) program will raise awareness about the dangers of sharing medications and work with medical communities on the risk of over-prescribing to young adults. It will also raise community awareness and bring prescription drug abuse prevention activities and education to schools, communities, parents, prescribers, and their parents. In addition, SAMHSA will track opioid overdoses and the incorporation of PDMP data into needs assessments and strategic plans as indicators of the program success.

A 2021 Strategic Prevention Framework for Prescription Drugs (SPF Rx) grant will allow the Iowa Department of Public Health (IDPH), Division of Behavioral Health, to continue collaborative work to reduce prescription drug misuse among Iowans ages 12-25 by raising awareness about the dangers of sharing medications and the risks of overprescribing to young adults. Although there has been a downward trend in prescription drug misuse among Iowa's young people over the past five years, Iowa youth ages 12-17 misused pain relievers at the second highest rate in the nation in 2018-19. And Iowa has the third highest rate of misused pain relievers in the US among all individuals over age 12. The proposed catchment areas will be three high-need Iowa counties, to be selected using a Request for Proposal (RFP) process that evaluates the need for SPF Rx programming based on Prescription Monitoring Program (PMP) and other indicators including: opioid-related treatment admissions and overdose deaths, poisoning hospitalizations, prescription drug use not prescribed by doctor (among youth in 6th, 8th and 11th grades), number of residents prescribed opioid analgesics, and number of opioid pills dispensed. The three sub-recipient counties will receive SPF Rx funding for infrastructure development and prescription drug prevention services designed to reduce opioid overdoses all while using SPF processes and deliverables. IDPH and sub-recipient counties will implement strategies including a SPF Rx media campaign ""Prescription Drugs Are Still Drugs"", and information dissemination of SAMHSA's Opioid Overdose Prevention Toolkit and the CDC Guidelines for Prescribing Opioids for Chronic Pain. Each county will select an additional strategy for a total of three strategies to reach targeted audiences. Services will impact all Iowa residents over age 12, but efforts will be focused on the two age groups where prevention services can affect future prescription drug misuse (youth ages 12-17 and young adults ages 18-25). IDPH's SPF Rx goals are to: 1) Decrease prescription drug misuse throughout Iowa, and prioritize and mobilize comprehensive efforts in the highest-need counties; 2) Reduce the consequences of nonmedical use of prescription drugs; 3) Use Iowa PMP data in the development of population-level interventions; and 4) Apply the SPF planning methods to the SPF Rx sub-recipients. By the end of Year 5, sub-recipients will have educated at least 50 percent of their populations ages 12-17 and 18-25 on the dangers of the misuse of prescription drugs with strategies implemented through the SPF process; and IDPH will have reached at least 50 percent (297,202) of Iowa's population ages 12-25. Services in the three counties will reach a total of 63,145 people over the grant period (15,786/year for four years).